Literature DB >> 21343544

Characterization of glucose-insulin responsiveness and impact of fetal number and sex difference on insulin response in the sheep fetus.

Alice S Green1, Antoni R Macko, Paul J Rozance, Dustin T Yates, Xiaochuan Chen, William W Hay, Sean W Limesand.   

Abstract

GSIS is often measured in the sheep fetus by a square-wave hyperglycemic clamp, but maximal β-cell responsiveness and effects of fetal number and sex difference have not been fully evaluated. We determined the dose-response curve for GSIS in fetal sheep (0.9 of gestation) by increasing plasma glucose from euglycemia in a stepwise fashion. The glucose-insulin response was best fit by curvilinear third-order polynomial equations for singletons (y = 0.018x(3) - 0.26x(2) + 1.2x - 0.64) and twins (y = -0.012x(3) + 0.043x(2) + 0.40x - 0.16). In singles, maximal insulin secretion was achieved at 3.4 ± 0.2 mmol/l glucose but began to plateau after 2.4 ± 0.2 mmol/l glucose (90% of maximum), whereas the maximum for twins was reached at 4.8 ± 0.4 mmol/l glucose. In twin (n = 18) and singleton (n = 49) fetuses, GSIS was determined with a square-wave hyperglycemic clamp >2.4 mmol/l glucose. Twins had a lower basal glucose concentration, and plasma insulin concentrations were 59 (P < 0.01) and 43% (P < 0.05) lower in twins than singletons during the euglycemic and hyperglycemic periods, respectively. The basal glucose/insulin ratio was approximately doubled in twins vs. singles (P < 0.001), indicating greater insulin sensitivity. In a separate cohort of fetuses, twins (n = 8) had lower body weight (P < 0.05) and β-cell mass (P < 0.01) than singleton fetuses (n = 7) as a result of smaller pancreata (P < 0.01) and a positive correlation (P < 0.05) between insulin immunopositive area and fetal weight (P < 0.05). No effects of sex difference on GSIS or β-cell mass were observed. These findings indicate that insulin secretion is less responsive to physiological glucose concentrations in twins, due in part to less β-cell mass.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343544      PMCID: PMC3093975          DOI: 10.1152/ajpendo.00572.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  43 in total

1.  Effects of fetal intravenous glucose challenge in normal and growth retarded fetuses.

Authors:  U Nicolini; C Hubinont; J Santolaya; N M Fisk; C H Rodeck
Journal:  Horm Metab Res       Date:  1990-08       Impact factor: 2.936

2.  The effects of pancreatectomy on the rates of glucose utilization, oxidation and production in the sheep fetus.

Authors:  A L Fowden; W W Hay
Journal:  Q J Exp Physiol       Date:  1988-11

3.  An ultrastructural analysis of the developing embryonic pancreas.

Authors:  R L Pictet; W R Clark; R H Williams; W J Rutter
Journal:  Dev Biol       Date:  1972-12       Impact factor: 3.582

4.  Thresholds for physiological effects of plasma catecholamines in fetal sheep.

Authors:  J F Padbury; J K Ludlow; M G Ervin; H C Jacobs; J A Humme
Journal:  Am J Physiol       Date:  1987-04

5.  Development of insulin release by fetal rat pancreas in vitro: effects of glucose, amino acids, and theophylline.

Authors:  A Kervran; J Randon
Journal:  Diabetes       Date:  1980-09       Impact factor: 9.461

6.  Dynamics of glucose-induced plasma insulin increase in the rat fetus at different stages of gestation. Effects of maternal hypothermia and fetal decapitation.

Authors:  A Kervran; J Randon; J R Girard
Journal:  Biol Neonate       Date:  1979

7.  Effects of insulin infusion on plasma catecholamine concentration in fetal sheep.

Authors:  B S Stonestreet; G J Piasecki; J B Susa; B T Jackson
Journal:  Am J Obstet Gynecol       Date:  1989-03       Impact factor: 8.661

8.  The effects of streptozotocin on rates of glucose utilization, oxidation, and production in the sheep fetus.

Authors:  W W Hay; H K Meznarich; A L Fowden
Journal:  Metabolism       Date:  1989-01       Impact factor: 8.694

9.  Maturation of early-phase insulin release in the neonatal lamb.

Authors:  A F Philipps; J W Dubin; J R Raye
Journal:  Biol Neonate       Date:  1981

10.  Plasma insulin in appropriate- and small-for-gestational-age fetuses.

Authors:  D L Economides; A Proudler; K H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

View more
  24 in total

1.  Size at birth and adult fat mass in twin sheep are determined in early gestation.

Authors:  S N Hancock; M H Oliver; C McLean; A L Jaquiery; F H Bloomfield
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

2.  A Chronic Fetal Leucine Infusion Potentiates Fetal Insulin Secretion and Increases Pancreatic Islet Size, Vascularity, and β Cells in Late-Gestation Sheep.

Authors:  Brit H Boehmer; Laura D Brown; Stephanie R Wesolowski; William W Hay; Paul J Rozance
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

3.  Increased adrenergic signaling is responsible for decreased glucose-stimulated insulin secretion in the chronically hyperinsulinemic ovine fetus.

Authors:  Sasha E Andrews; Laura D Brown; Stephanie R Thorn; Sean W Limesand; Melissa Davis; William W Hay; Paul J Rozance
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

4.  Elevated plasma norepinephrine inhibits insulin secretion, but adrenergic blockade reveals enhanced β-cell responsiveness in an ovine model of placental insufficiency at 0.7 of gestation.

Authors:  A R Macko; D T Yates; X Chen; A S Green; A C Kelly; L D Brown; S W Limesand
Journal:  J Dev Orig Health Dis       Date:  2013-10       Impact factor: 2.401

5.  Chronic pulsatile hyperglycemia reduces insulin secretion and increases accumulation of reactive oxygen species in fetal sheep islets.

Authors:  Alice S Green; Xiaochuan Chen; Antoni R Macko; Miranda J Anderson; Amy C Kelly; Nathaniel J Hart; Ronald M Lynch; Sean W Limesand
Journal:  J Endocrinol       Date:  2011-12-19       Impact factor: 4.286

6.  Islet adaptations in fetal sheep persist following chronic exposure to high norepinephrine.

Authors:  Xiaochuan Chen; Amy C Kelly; Dustin T Yates; Antoni R Macko; Ronald M Lynch; Sean W Limesand
Journal:  J Endocrinol       Date:  2016-11-25       Impact factor: 4.286

7.  Postnatal effects of intrauterine treatment of the growth-restricted ovine fetus with intra-amniotic insulin-like growth factor-1.

Authors:  A M Spiroski; M H Oliver; A L Jaquiery; T C R Prickett; E A Espiner; J E Harding; F H Bloomfield
Journal:  J Physiol       Date:  2017-12-27       Impact factor: 5.182

8.  Hypoxaemia-induced catecholamine secretion from adrenal chromaffin cells inhibits glucose-stimulated hyperinsulinaemia in fetal sheep.

Authors:  Dustin T Yates; Antoni R Macko; Xiaochuan Chen; Alice S Green; Amy C Kelly; Miranda J Anderson; Abigail L Fowden; Sean W Limesand
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

9.  Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase β-cell mass in fetal sheep.

Authors:  Monika M Gadhia; Anne M Maliszewski; Meghan C O'Meara; Stephanie R Thorn; Jinny R Lavezzi; Sean W Limesand; William W Hay; Laura D Brown; Paul J Rozance
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

10.  Chronically Increased Amino Acids Improve Insulin Secretion, Pancreatic Vascularity, and Islet Size in Growth-Restricted Fetal Sheep.

Authors:  Laura D Brown; Melissa Davis; Sandra Wai; Stephanie R Wesolowski; William W Hay; Sean W Limesand; Paul J Rozance
Journal:  Endocrinology       Date:  2016-08-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.